retinoid X receptor alpha, the group of MicroRNA protein coding host genes|Retinoid X receptors

Basic information

Region (hg38): 9:134317097-134440585





Source: genCC

No genCC data.


This is a list of variants' phenotypes submitted to ClinVar and linked to the RXRA gene.

  • not provided (3 variants)
  • Inborn genetic diseases (3 variants)
  • Transitional cell carcinoma of the bladder (2 variants)
  • Pancreatic adenocarcinoma (2 variants)
  • Hepatocellular carcinoma (2 variants)
  • Multiple myeloma (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RXRA gene is commonly pathogenic or not.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous 2 2
missense 3 3 6
nonsense 0
start loss 0
frameshift 0
inframe indel 0
splice variant 1 1
non coding 0
Total 0 3 4 2 0

Variants in RXRA

This is a list of pathogenic ClinVar variants found in the RXRA region.

Position Type Phenotype Significance ClinVar
9-134319017-T-C Levothyroxine response drug response (-)link
9-134326660-G-A Uncertain significance (Oct 07, 2020)link
9-134401726-C-T Likely benign (Jul 17, 2018)link
9-134401735-G-A Likely benign (May 21, 2018)link
9-134409080-C-T Inborn genetic diseases Uncertain significance (Jan 25, 2023)link
9-134409102-T-C Inborn genetic diseases Uncertain significance (Mar 07, 2023)link
9-134417195-C-A Inborn genetic diseases Uncertain significance (Jan 26, 2022)link
9-134417218-G-A Multiple myeloma Likely pathogenic (Aug 31, 2019)link
9-134417221-G-A Inborn genetic diseases Uncertain significance (Jun 05, 2023)link
9-134434138-C-T Inborn genetic diseases Uncertain significance (Dec 13, 2022)link
9-134436505-C-A Pancreatic adenocarcinoma • Transitional cell carcinoma of the bladder • Hepatocellular carcinoma Likely pathogenic (May 31, 2016)link
9-134436505-C-T Transitional cell carcinoma of the bladder • Pancreatic adenocarcinoma • Hepatocellular carcinoma Likely pathogenic (May 31, 2016)link
9-134436595-C-T Inborn genetic diseases Uncertain significance (Dec 14, 2021)link


Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RXRAprotein_codingprotein_codingENST00000481739 10123488
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense in Polyphen50145.040.344731368
Loss of Function4.04019.00.008.89e-7228

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00


Source: dbNSFP

FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes. {ECO:0000269|PubMed:10195690, ECO:0000269|PubMed:11162439, ECO:0000269|PubMed:11915042, ECO:0000269|PubMed:20215566}.;
PI3K-Akt signaling pathway - Homo sapiens (human);Non-small cell lung cancer - Homo sapiens (human);Gastric cancer - Homo sapiens (human);Adipocytokine signaling pathway - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Small cell lung cancer - Homo sapiens (human);Bile secretion - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Thyroid cancer - Homo sapiens (human);NHR;Vitamin D Metabolism;Energy Metabolism;Nuclear Receptors;Adipogenesis;Liver X Receptor Pathway;Constitutive Androstane Receptor Pathway;Pregnane X Receptor pathway;Vitamin D Receptor Pathway;PPAR Alpha Pathway;Farnesoid X Receptor Pathway;Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;NRF2 pathway;Transcription factor regulation in adipogenesis;Angiopoietin Like Protein 8 Regulatory Pathway;PPAR signaling pathway;Prion disease pathway;PI3K-AKT-mTOR - VitD3 Signalling;role of ppar-gamma coactivators in obesity and thermogenesis;Vitamin A and Carotenoid Metabolism;Developmental Biology;Signal Transduction;Gene expression (Transcription);mechanism of gene regulation by peroxisome proliferators via ppara;visceral fat deposits and the metabolic syndrome;Phase I - Functionalization of compounds;transcription regulation by methyltransferase of carm1;nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells;Generic Transcription Pathway;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Metabolism of lipids;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;basic mechanism of action of ppara pparb(d) and pparg and effects on gene expression;Pyruvate metabolism and Citric Acid (TCA) cycle;Import of palmitoyl-CoA into the mitochondrial matrix;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Endogenous sterols;The citric acid (TCA) cycle and respiratory electron transport;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Transcriptional regulation of white adipocyte differentiation;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Synthesis of bile acids and bile salts;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Fatty acid metabolism;Metabolism of steroids;degradation of the rar and rxr by the proteasome;Signaling by Retinoic Acid;Signaling by Nuclear Receptors;a6b1 and a6b4 Integrin signaling;RXR and RAR heterodimerization with other nuclear receptor;TNFalpha;Retinoic acid receptors-mediated signaling;Regulation of Androgen receptor activity (Consensus)

Recessive Scores


Intolerance Scores


Haploinsufficiency Scores




Gene Damage Prediction

Primary ImmunodeficiencyMediumMediumMedium

Mouse Genome Informatics

Gene name
endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; muscle phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; pigmentation phenotype; neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;in utero embryonic development;maternal placenta development;transcription initiation from RNA polymerase II promoter;vitamin metabolic process;embryo implantation;cholesterol metabolic process;bile acid and bile salt transport;modulation by virus of host morphology or physiology;regulation of lipid metabolic process;response to retinoic acid;peroxisome proliferator activated receptor signaling pathway;camera-type eye development;steroid hormone mediated signaling pathway;positive regulation of transcription by RNA polymerase II;positive regulation of translational initiation by iron;retinoic acid receptor signaling pathway;protein homotetramerization;ventricular cardiac muscle tissue morphogenesis;ventricular cardiac muscle cell differentiation;cardiac muscle cell proliferation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;regulation of branching involved in prostate gland morphogenesis
Cellular component
nuclear chromatin;nucleus;nucleoplasm;protein-containing complex;receptor complex;RNA polymerase II transcription factor complex
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;retinoic acid binding;DNA binding;double-stranded DNA binding;DNA-binding transcription factor activity;steroid hormone receptor activity;transcription coactivator activity;nuclear receptor activity;protein binding;zinc ion binding;nuclear receptor binding;enzyme binding;chromatin DNA binding;signaling receptor activity;peptide binding;vitamin D receptor binding;sequence-specific DNA binding;transcription regulatory region DNA binding;retinoic acid-responsive element binding;protein heterodimerization activity;DBD domain binding;LBD domain binding;vitamin D response element binding